Then we collected tissue samples of 10 HCC patients from clinical sources for transcript sequencing and found that their individual expression differences were consistent with the TCGA database, and it was obvious that FGFR4 had a significant and stable trend, which was more representative (Supplementary Figure S1B, S1C). Here, FGFR4 is linked to hepatocellular carcinoma.